NEW YORK, March 16 (GenomeWeb News) - Advanced Bio/Chem has licensed breast cancer protein biomarker technology from the University of Texas' M.D. Anderson Cancer Center, the company said today.
ProteEx, located in The Woodlands, Texas, is doing business as Advanced Bio/Chem.
The technology, relying on proteomic analysis of breast ductal fluids, was jointly developed by the company and UT M.D. Anderson.